Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

Bennett Levitan,1 Zhong Yuan,1 Alexander GG Turpie,2 Richard J Friedman,3 Martin Homering,4 Jesse A Berlin,1 Scott D Berkowitz,5 Rachel B Weinstein,1 Peter M DiBattiste61Janssen Research & Development, LLC, Titusville, NJ, USA; 2Hamilton Health Sciences McMaster Clinic, McMaster University,...

Full description

Bibliographic Details
Main Authors: Levitan B, Yuan Z, Turpie AGG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM
Format: Article
Language:English
Published: Dove Medical Press 2014-03-01
Series:Vascular Health and Risk Management
Online Access:http://www.dovepress.com/benefitndashrisk-assessment-of-rivaroxaban-versus-enoxaparin-for-the-p-a16226

Internet

http://www.dovepress.com/benefitndashrisk-assessment-of-rivaroxaban-versus-enoxaparin-for-the-p-a16226

Similar Items